Wolverine Asset Management LLC F Star Therapeutics, Inc. Transaction History

Wolverine Asset Management LLC

  • $4.23 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023
BUY
$4.09 - $6.86 $16,920 - $28,379
4,137 Added 8.81%
51,101 $322,000
Q3 2022

Nov 10, 2022
BUY
$5.41 - $6.74 $242,173 - $301,709
44,764 Added 2034.73%
46,964 $240,000
Q2 2022

Aug 03, 2022
BUY
$2.18 - $6.39 $4,796 - $14,058
2,200 New
2,200 $13,000

Others Institutions Holding FSTX

# of Institutions
3
Shares Held
44.7K
Call Options Held
0
Put Options Held
0
View Full List

About F-star Therapeutics, Inc.

FSTX Quotes by TradingView
  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email